💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Celltrion Inc (068270)

Seoul
Currency in KRW
Disclaimer
191,200
+3,200(+1.70%)
Closed
068270 Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
185,500192,500
52 wk Range
131,000241,000
Bid/Ask
191,200.00 / 191,300.00
Prev. Close
188,000
Open
188,100
Day's Range
185,500-192,500
52 wk Range
131,000-241,000
Volume
655,429
Average Volume (3m)
830,032
1-Year Change
29.63%
Fair Value
Unlock
Fair Value Upside
Unlock
068270 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
246,778.00
Upside
+29.07%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Celltrion Inc Company Profile

Celltrion, Inc., together with its subsidiaries, develops and produces drugs based on proteins for the treatment of oncology in South Korea. The company markets bio pharmaceuticals; generic pharmaceuticals; and covid-19 test kits. Its antibody biosimilar pipeline includes CT-P39 that is in phase 3 clinical trial for the treatment of asthma and urticaria; CT-P41, which is in phase 3 clinical trial for the treatment of osteoporosis and bone loss; CT-P42, which is in phase 3 clinical trial for the treatment of diabetic macular edema; and CT-P43 that is in phase 3 clinical trial for the treatment of psoriasis, crohn's disease, and ulcerative colitis. The company also offers CT-P47, which is in phase 3 clinical trial for the treatment of rheumatoid arthritis; and CT-P53 that is is in phase 3 clinical trial for the treatment of multiple sclerosis. Celltrion, Inc. was founded in 2002 and is headquartered in Incheon, South Korea.

Compare 068270 to Peers and Sector

Metrics to compare
068270
Peers
Sector
Relationship
P/E Ratio
122.0x13.4x−0.6x
PEG Ratio
−2.360.010.00
Price/Book
2.3x1.8x2.6x
Price / LTM Sales
14.8x2.2x3.1x
Upside (Analyst Target)
30.8%12.7%58.1%
Fair Value Upside
Unlock11.7%9.2%Unlock

People Also Watch

965,000
207940
+3.21%
216,000
003670
-7.89%
158,100
247540
-5.39%
77,900
086520
-6.93%
301,000
196170
-1.95%

FAQ

What Is the Celltrion (068270) Stock Price Today?

The Celltrion stock price today is 191,200.00

What Stock Exchange Does Celltrion Trade On?

Celltrion is listed and trades on the Seoul stock exchange.

What Is the Stock Symbol for Celltrion?

The stock symbol for Celltrion is "068270."

Does Celltrion Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.26%.

What Is the Celltrion Market Cap?

As of today, Celltrion market cap is 39.46T.

What is Celltrion Earnings Per Share?

The Celltrion EPS is 1,852.23.

What Is the Next Celltrion Earnings Date?

Celltrion will release its next earnings report on 10 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.